Last reviewed · How we verify
Hyperphosphatemia
Approved treatments
- Ferrlecit · Vifor Fresenius
Ferrlecit binds to dietary phosphate in the gut, preventing its absorption into the bloodstream. - Auryxia · Keryx Biopharms
Auryxia works by binding to phosphate in the gut, reducing its absorption, and also providing iron to the body. - Colestimide · Tanabe Pharma Corporation
Colestimide works by inhibiting the absorption of cholesterol and/or phosphorus in the intestines. - Velphoro · RWTH Aachen University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hyperphosphatemia patent landscape — cliff calendar, originator estates, attackable patents
- Hyperphosphatemia treatment landscape brief
- Hyperphosphatemia treatment updates RSS
Frequently asked questions about Hyperphosphatemia
What drugs treat Hyperphosphatemia?
Tracked treatments include Ferrlecit, Auryxia, Colestimide, Velphoro.
What is the treatment for Hyperphosphatemia?
Standard treatment for Hyperphosphatemia includes Ferrlecit, Auryxia, Colestimide, Velphoro. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hyperphosphatemia patent cliff · Hyperphosphatemia CI report
- Treatment: Ferrlecit · Vifor Fresenius
- Treatment: Auryxia · Keryx Biopharms
- Treatment: Colestimide · Tanabe Pharma Corporation
- Treatment: Velphoro · RWTH Aachen University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing